ProCE Banner Activity

The Importance of MRD Testing in Acute Lymphoblastic Leukemia

Clinical Thought
New data emphasize the importance of MRD testing in patients with ALL

Released: July 27, 2018

Expiration: July 26, 2019

No longer available for credit.

Share

Faculty

Elias Jabbour

Elias Jabbour, MD

Assistant Professor
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by educational grants from

Adaptive Biotechnologies

Amgen, Inc.

Partners

GRACE

ProCE Banner

Program Director Disclosure

Program Director

Elias Jabbour, MD

Assistant Professor
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Elias Jabbour, MD, has disclosed that he has received funds for research support from Bristol-Meyers Squibb, Novartis, AbbVie, Takeda, Amgen, and Pfizer.